Newsroom Stories

The Setton lab leads an interdisciplinary team researching potential treatments for intervertebral disc disease.

The stay-at-home orders during the peak of the COVID-19 pandemic in 2020 led to a decrease in children’s physical activity and in increase in screen time, finds two new studies from the Brown School.

Researchers in the McKelvey School of Engineering and at the University of Virginia recently developed a high-tech imaging technique that opens up opportunities to study dysfunction in acute and chronic kidney disease.

A research team at Washington University School of Medicine has identified potential new treatment targets for Alzheimer’s disease, as well as existing drugs that have therapeutic potential against these targets.

George and Carol Bauer, longtime generous benefactors of Washington University in St. Louis, have made a $6 million commitment to establish a new leadership and character development initiative at the university.

Washington University has renewed its commitment to the American Talent Initiative’s Accelerating Opportunity campaign, a nationwide effort to graduate an additional 50,000 low- and moderate-income students from ATI member colleges and universities by 2025.

A study in the Proceedings of the National Academy of Sciences led by Michael Moore, a postdoctoral fellow with the Living Earth Collaborative, finds that dragonfly males have consistently evolved less breeding coloration in regions with hotter climates.

Researchers examine a 4.6 billion- year-old rock to better understand the solar system’s beginning, and a modern mystery.

Antibiotic sales soared during India’s first surge of COVID-19, suggesting that the drugs were inappropriately used to treat mild and moderate COVID-19 infections, according to research led by the School of Medicine. Such overuse increases the risk for drug-resistant infections worldwide.

Using top-of-the-line research instrumentation from Agilent and Merck, scientists in the Department of Chemistry in Arts & Sciences will develop new metabolomics workflows of interest to many members of the drug-development community.